BioWorld

June 16, 2005

Chiron Lowers Estimates For Flu Vaccine Production

Chiron Inc. has reduced its estimated production range for Fluvirin, citing delays in start-up procedures, as the company gears up for full vaccine production for the 2005-2006 flu season. (BioWorld Today) Read More

NeurogesX Starts Phase III Study Of NGX-4010 In Pain

Despite Detractors, Crawford Nomination Moving Forward

Research Heritage In Flanders Bringing Commercial Success

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for April 2, 2026.

With improved technologies, biomarkers, failed drugs may come into their own

BioWorld

At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...

Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

Small-molecule TREM2 agonist advances to treat Alzheimer’s

BioWorld Science

Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...

Amlogenyx’s AM-805 reduces amyloid plaques in AD

BioWorld Science

The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 31, 2026